The data demonstrated that BR therapy significantly reduced the levels of proinflammatory cytokines interleukin (IL)-1β, IL-6, TNF-α, and the chemokine, CXCL1, at 8 h post stroke and further reduced IL-6, IFN-γ, and TNF-α at 23 h post stroke. Here, CXCL1 is linked to stroke disorder.